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Abstract
Purpose: To measure the tissue sulfomucin and sialomucin content of the colon mucosa 
without fecal flow, subjected to intervention with curcumin, and the influence of the 
concentration used and the intervention time. 
Methods: Thirty-six rats were subjected to proximal right colostomy and distal mucous 
fistula. They were divided into two groups according to whether sacrifice was performed two 
or four weeks after the intervention. Each group was divided into three subgroups according 
to the enema applied daily: saline alone; curcumin at 50 mg/kg/day or curcumin at 200 mg/
kg/day. Acid mucins were diagnosed using the Alcian blue technique. The mucin content was 
quantified by means of computer-assisted image analysis. The significance level of 5% was 
used throughout (p < 0.05).
Results: There were dose-related increases in the quantities of sulfomucins in the animals 
subjected to interventions with curcumin, both after two weeks (p < 0.00001) and after four 
weeks (p < 0.00001). There were increases in sialomucin quantity that were concentration-
related (p < 0.00001) and time-related (p < 0.00001).
Conclusion: Curcumin enemas increase the quantity of acid mucins in the intestinal flow in 
the excluded colon, with dose and time dependency.
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supply of short-chain fatty acids (SCFA) to the 
cells of the colonic epithelium consequent to 
intestinal exclusion9-16. These experimental 
studies have also shown that cells that have 
been deprived of SCFA supply undergo 
modification of their energy metabolism, with 
consequently greater production of oxygen 
free radicals (OFRs). When OFRs are not 
neutralized by the antioxidant systems of the 
colon mucosa, they damage the mechanical 
protection of the mucosa, particularly the 
mucus layer that covers the surface of the 
epithelium6,17. 
 It has been shown that application 
of enemas containing natural or synthetic 
substances with antioxidant effect is capable 
of reducing the inflammation of the mucosa of 
the excluded colon8,18-19. One such substance is 
curcumin, an extract from Curcuma Longa, to 
which a variety of medicinal properties have 
been attributed. Curcumin is extracted from 
the rhizome of this plant and is recognized for 
its prominent effect of removal of OFRs that 
are formed during inflammatory responses 
[20]. Because of its anti-inflammatory and 
antioxidant action, it has been used to treat 
different illnesses that involve IBD21-24.
 The oxidative stress in colitis of the 
excluded colon that results from increased 
production of OFRs modifies the content 
and expression pattern of the carbohydrate 
fraction of the mucins of epithelial glands5,17. 
Moreover, Curcuma longa possesses proven 
antioxidant effects20. In this light, it becomes 
a matter of interest to ascertain the effects 
of applying curcumin enemas to the content 
and expression pattern of acid mucins and 
their subtypes. However, to the best of our 
knowledge, this evaluation has not yet been 
conducted.
 Thus, the objective of the present study 
was to evaluate the content and expression 
pattern of acid mucins in the mucosa of the 
colon after exclusion from fecal transit and 
 ■ Introduction
 The mucosa of the colon functions as 
a protective barrier that separates the large 
quantities of bacteria, antigens and toxins 
present inside the intestinal lumen from the 
sterile environment1-4. This mucosal barrier 
promotes protection that is both mechanical 
and immunological5-6. The mechanical 
protection consists mainly of the mucus 
layer that covers the epithelium, cytoplasmic 
membranes, intercellular junction systems and 
basal membrane5-6. The immunological barrier 
is provided by different defense cells, which 
make the intestine the biggest lymphoid organ 
in the human body. 
 The mucus barrier that covers the 
colon mucosa is the first line of defense. This 
layer provides protection against the trauma 
resulting from fecal transit and also has 
bacteriostatic and bactericidal action. The 
mucus that covers the intestinal epithelium is 
formed mostly by mucins, which are molecules 
composed of both a carbohydrate fraction and 
a protein fraction. In the carbohydrate portion 
of the molecule, the mucins belong to two main 
groups: neutral and acid types1-7. In turn, the 
acid mucins consist of two subtypes, according 
to whether sulfate radicals (sulfomucins) or 
sialic acid radicals (sialomucins) predominate 
in the molecule1. 
 The tissue expression of mucins has 
been found to be altered in different intestinal 
illnesses, and particularly in intestinal infectious 
diseases, inflammatory bowel diseases (IBD) 
and colorectal cancer. A series of experimental 
studies has demonstrated that the tissue 
mucin content in colon segments excluded 
from the intestinal transit becomes modified. 
Colitis of the excluded colon is a form of IBD 
that affects segments of the large intestine that 
have been deprived of intestinal transit8. The 
pathogenesis of colitis of the excluded colon 
has been correlated with deficiency of regular 
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application of enemas containing curcumin. 
The study also aimed to ascertain whether 
the effect of this substance was related to the 
concentration used and the duration of the 
intervention.
 ■ Methods
 The experiments were performed in 
accordance with the principles outlined in 
Federal Law no. 11.794 (August 10, 2008) and 
were approved by the Ethics Committee for 
Animal Research, Universidade São Francisco 
(approval no. 2211/2007).
 Thirty-six male Wistar rats (weighing 
300-350g) were obtained from the animal colony 
of the School of Medicine, USF. They were kept 
under conditions of light/dark cycles of 12 hours 
each, and were fed a standard rodent chow diet. 
They were deprived of food, but not water, for 
24 h prior to the surgical procedure. 
Surgical technique
 Diversion of the fecal flow was performed 
in all animals under general anesthesia that was 
attained through intramuscular administration of 
0.1 ml/100 g of a 1:1 (v/v) solution of ketamine (50 
mg/ml) and xylazine (20 mg/ml). The abdomen 
was shaved, and a 3 cm-long midline incision 
was made. The left colon was exteriorized and 
sectioned in its mid-portion, corresponding 
to the descending colon, approximately 3 cm 
above Peyer’s lymphoid patch (which is located 
at the rectal-sigmoid transition). Two circular 
skin pellets, 3 mm in diameter and 3 cm apart, 
were made in the left side of the abdominal wall 
at the same vertical level. The proximal end of 
the colon was exteriorized through the cranial 
cutaneous orifice, and the distal stoma was 
exteriorized through the caudal skin opening 
after splitting the abdominal wall muscles. The 
proximal end and the distal stoma were fixed 
to the skin with full-thickness sutures. Before 
fixation of the distal stoma to the skin, the distal 
colon was cleaned by means of infusion of a 
physiological solution until the fecal contents 
had been completely removed. The abdominal 
incision was closed in two stages: aponeurosis 
and skin. Thus, two colostomies were performed: 
a proximal colostomy, as a terminal colostomy 
with intestinal transit; and a second colostomy, 
as a distal stoma devoid of fecal flow. The rats 
were kept in individual cages, without any 
particular care taken with regard to the stomas 
and abdominal incisions.
Experimental groups
 Figure 1 shows the division of the 
experimental groups. The animals were divided 
into two experimental groups with 18 animals 
each, according to whether the animals 
would be sacrificed after two or four weeks. 
Each experimental group was divided into six 
subgroups (n = 6) according to the intervention 
used and duration of intervention. In the first 
and second subgroups, 12 animals received daily 
rectal enemas containing 20 ml of 0.9% saline 
solution (control subgroup) at 37ºC for two 
weeks (n = 6) or four weeks (n = 6). In the second 
subgroup, 12 animals received daily rectal 
enemas containing 20 ml of curcumin (Sigma-
Aldrich, St Louis, MO, USA) at a concentration of 
50 mg/kg for two weeks (n = 6) or four weeks 
(n = 6). Finally, 12 animals in the third subgroup 
received daily enemas containing 20 ml of 
curcumin at a concentration of 200 mg/kg for 
two weeks (n = 6) or four weeks (n = 6). In order 
to standardize the speed of application and the 
time taken to do it, the enemas for all animals 
were administered using an infusion pump for 
which the speed had been standardized at 20/
ml/min.
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Sample collection
 Upon completion of the predetermined 
irrigation period, the animals were 
anesthetized as described above, and the 
midline incision was opened again. In both 
groups, specimens were taken from the intra-
abdominal part of the excluded colon without 
fecal flow, which had been subjected to 
irrigation using the proposed substances. The 
specimen removed, measuring approximately 
4.0 cm, was opened longitudinally through the 
antimesenteric border, while fixed to a piece 
of cork, and was then sent for histological 
and histochemical analysis. The animals were 
sacrificed with an intracardiac lethal dose of 
thiopental and the carcasses were incinerated. 
Histological and histochemical analysis
 Fragments prepared for histological 
analysis were immersed in 10% neutral 
formalin buffer (Sigma-Aldrich, St. Louis, 
MO, USA) for 24 h, dehydrated by means of 
exposure to increasing ethanol concentrations, 
and embedded in paraffin. Tissue sections of 
thickness 5 µm were then cut using a rotary 
microtome (Leica Biosystems, Nussloch, 
Germany), mounted on glass slides, cleared, 
hydrated and stained with hematoxylin-eosin 
(HE) for evaluation of the presence of colitis. 
The analysis on the slides was performed under 
an optical microscope (Eclipse DS-50, Nikon 
Inc., Osaka, Japan) with final magnification of 
x200. Photomicrographs were taken using a 
digital video-capture camera (DS-Fi-50; Nikon 
Inc., Osaka, Japan) coupled to the microscope 
body. The images were digitized by means of 
a computer system for image analysis (NIS-
Elements; Nikon Inc., Osaka, Japan). 
 The diagnosis of colitis was made 
based on the presence of three independent 
histological parameters: reduction of the crypt 
length, neutrophil infiltration of the mucosa 
and epithelial loss. These variables were 
stratified as crosses, according to the degree 
of each variable, as follows: a) + absent or no 
alterations; b) ++ when intensity was mild; c) 
+++ moderate; and d) ++++ intense. For all 
variables analyzed, the final value considered 
for each animal was the mean value after 
quantification of three distinct histological 
fields.
 The tissue acid mucin expression was 
determined individually by means of the Alcian 
blue (AB) histochemical technique. The total 
acid mucin content stained blue. To identify 
the subtypes of acid mucins (sulfomucins and 
sialomucins), the slides were stained using 
the high iron diamine-Alcian blue (HID-AB) 
histochemical technique, in accordance with 
the standardized methodology. In summary, 
the slides were deparaffinized in two 
successive xylol baths for 10 minutes, treated 
with an alcohol rinse in three successive 
baths of pure alcohol and then hydrated in 
running water for five minutes. After this 
step, they were washed in three successive 
baths of distilled water and then exposed to 
high-iron diamine (HID) for six hours. The HID 
solution consisted of 120 mg of NN-dimethyl-
meta-phenylenediamine-dihydrochloride, 20 
mg of NN-dimethyl-paraphenylenediamine-
dihydrochloride, 50 ml of distilled water and 
1.4 ml of a recently prepared solution of 60% 
ferric chloride. At the end of the HID staining, 
the sections were washed in running water 
Figure 1 - Subdivision of the experimental groups. 	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for five minutes and then in three successive 
baths of distilled water. Subsequently, they 
were exposed to the staining agent Alcian 
blue (AB) for 10 minutes and then washed 
in running water for five minutes followed 
by three successive baths of distilled water. 
The 1% AB staining medium was prepared in 
acetic acid (pH 2.5). At the end of this step, 
the slides were counterstained with neutral 
red for eight minutes and washed again in 
running water. They were then dehydrated 
in three successive baths of pure alcohol and 
diaphanized in three baths of xylol, and cover 
slips were mounted using resin. Through the 
HID-AB technique, sulfomucins stained brown 
and sialomucins stained blue. A pathologist 
with expertise in diseases of the digestive 
tract, who was unaware of the origin of the 
material and objectives of the study, evaluated 
the presence of colitis and the pattern of 
tissue expression. 
Computer-assisted image processing
 The tissue acid mucin content 
(sulfomucins and sialomucins) was quantified 
by means of computer-assisted image 
processing and was always performed in a 
focal field in which there were at least three 
complete and contiguous colonic crypts, at a 
magnification of x200. The images selected 
were captured on a video camera that had 
been coupled to an optical microscope. These 
images were processed and analyzed using the 
NIS-Elements 3.1 software (Nikon Inc., Osaka, 
Japan), installed in a microcomputer. By means 
of colored histograms in the red, green and 
blue (RGB) system, the software determined 
the color intensity and the number of pixels 
in each selected field, and the final data were 
transformed into percentage expression 
per field analyzed (%/field). The final value 
measured for each section was the mean 
of the values found from evaluating three 
different fields. The presence of sulfomucins 
and sialomucins was quantified in the same 
glands.
Statistical analysis
 The statistical analysis on the results 
obtained was conducted using a significance 
level of 5% (p ≤ 0.05). The data from each 
colon segment analyzed in each experimental 
group were expressed as the mean value 
with the respective standard error and were 
analyzed using the Biostat for Windows 
statistical software (version 5.0).
 ■ Results
 There was no reduction in the 
inflammatory score in animals submitted to 
intervention with curcumin at a dose of 50 
mg/kg and 200 mg/kg for two weeks when 
compared to animals submitted to saline 
intervention. A decrease in the inflammatory 
score was founded in colon segments without 
fecal stream submitted to intervention with 
oil extract of curcumin at concentration of 
200 mg/kg for four week when compared 
with animals submitted to intervention with 
saline.  
 Figure 2 shows the sulfomucin content 
found in the colon segments without fecal 
flow after intervention with saline or 50 
mg/kg/day or 200 g/kg/day of curcumin oil 
extract over a two or four-week period. The 
results show that intervention with curcumin 
oil extract at a concentration of 50 mg/kg/day 
or 200 g/kg/day in a colon devoid of fecal flow 
significantly increased the sulfomucin content 
two or four weeks after irrigation, compared 
with animals in the control group (p < 0.01). 
The results also show that intervention with 
curcumin oil extract at a concentration of 200 
mg/kg/day in colon segments devoid of fecal 
flow significantly increased the sulfomucin 
content two or four weeks after irrigation, 
compared with animals subjected to irrigation 
at a concentration of 50 mg/kg/day.
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 Figure 3 shows the tissue sialomucin 
content found in the segments without fecal 
flow after interventions using saline and 50 
mg/kg/day and 200 mg/kg/day of curcumin 
oil extract after two or four weeks. The results 
show that intervention with curcumin oil 
extract at a concentration of 50 mg/kg/day 
significantly increased the sialomucin content 
four weeks after irrigation compared with 
animals in the control group and with animals 
subjected to intervention with curcumin at 
same concentration after two weeks. The 
intervention with curcumin oil extract at a 
concentration of 200 mg/kg/day significantly 
increased the sialomucin content two or four 
	  
Figure 2 - Tissue sulfomucin content after 
interventions using 0.9% physiological serum, 
curcumin (50 mg/kg/day) and curcumin (200 mg/
kg/day), after two or four weeks. ** = significant (p 
< 0.01) curcumin > 0.9% physiological serum; †† = 
significant (p < 0.01) curcumin (200 mg/kg/day) > 
curcumin (50 mg/kg/day). Mann Whitney test.
Figure 3 - Tissue sialomucin content after 
interventions using 0.9% physiological serum, 
curcumin (50 mg/kg/day) and curcumin (200 mg/
kg/day), after two or four weeks. ** = significant (p 
< 0.01) curcumin > 0.9% physiological serum; †† = 
significant (p < 0.01) curcumin (200 mg/kg/day) > 
curcumin (50 mg/kg/day). Mann Whitney test.
	  
weeks after irrigation, compared with animals 
in the control group (p < 0.01) and animals 
subjected to intervention at concentration of 
50 mg/kg/day, after two or four weeks (p < 
0.01).
 Table 1 shows the mean values with 
the corresponding standard errors for the 
variation in the tissue total acid mucin content 
(sulfomucins and sialomucins) in animals 
subjected to interventions using saline and 
curcumin oil extracts at concentrations of 50 
mg/kg/day and 200 mg/kg/day according to 
the duration of the intervention (two or four 
weeks). 
 It can be seen that the quantities of 
both subtypes (sulfomucins and sialomucins) 
were higher after four weeks, independent of 
the intervention substance used.
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 Table 2 compares the quantities of 
sulfomucin and sialomucin expressed in 
the tissue of the colon segment deprived of 
intestinal transit, after specific interventions 
using 0.9% physiological serum, curcumin 
(50 mg/kg/day) and curcumin (200 mg/kg/
day), taking into account the intervention 
substance and the dose used. It can be seen 
that the quantities of both acid mucins were 
greater after the intervention with 200 mg/kg/
day of curcumin, with statistically significant 
differences.
Table 1 - Influence of the duration of the intervention on tissue sulfomucin and sialomucin 
expression in the animals subjected to interventions using 0.9% physiological serum and 
curcumin oil extract at concentrations of 50 mg/kg/day and 200 mg/kg/day.
Intervention substance and 
concentration
Mean ± standard error p value
2 weeks 4 weeks
Sulfomucins
Control 14.0 ± 0.32 20.48 ± 0.24 < 0.0001
Curcumin (50 mg/kg/day) 5.22 ± 0.39 7.31 ± 0.61 < 0.004
Curcumin (200 mg/kg/day) 10.56 ± 0.36 14.61 ± 0.49 < 0.0001
Sialomucins
Control 0.471 ± 0.06 0.080 ± 0.01 < 0.0001
Curcumin (50 mg/kg/day) 0.157 ± 0.03 1.08 ± 0.12 < 0.0001
Curcumin (200 mg/kg/day) 0.743 ± 0.09 1.781 ± 0.09 < 0.0001
Mann-Whitney. 4 weeks x 2 weeks.
Table 2 - Influence of the concentration used on tissue sulfomucin and sialomucin expression in 
the animals subjected to interventions using 0.9% physiological serum and curcumin oil extract at 
concentrations of 50 mg/kg/day and 200 mg/kg/day, after two or four weeks of intervention.
Mean ± standard error
Intervention substance 
and concentration
0.9% 
physiological 
serum
Curcumin
50 mg/kg/day
Curcumin
200 mg/kg/day
p value
Sulfomucins
    Two weeks 14.0 ± 0.32 5.22 ± 0.39 10.56 ± 0.36 < 0.00001
    Four weeks 20.48 ± 0.24 7.31 ± 0.61 14.61 ± 0.49 < 0.00001
Sialomucins
    Two weeks 0.471 ± 0.06 0.157 ± 0.03 0.743 ± 0.09 < 0.0004
    Four weeks 0.08 ± 0.01 1.08 ± 0.12 1.78 ± 0.09 < 0.0001
ANOVA test.
Sulfomucins: two weeks: 0.9% physiological serum > curcumin (50 mg/kg/day); 0.9% physiological serum > curcumin (200 mg/kg/
day); curcumin (200 mg/kg/day) > curcumin (50 mg/kg/day). Four weeks: 0.9% physiological serum > curcumin (50 mg/kg/day); 0.9% 
physiological serum > curcumin (200 mg/kg/day); curcumin (200 mg/kg/day) > curcumin (50 mg/kg/day).
Sialomucins: two weeks: 0.9% physiological serum versus curcumin (50 mg/kg/day); 0.9% physiological serum versus curcumin (200 
mg/kg/day); curcumin (200 mg/kg/day) versus curcumin (50 mg/kg/day). Four weeks: 0.9% physiological serum < Curcuma longa (50 
mg/kg/day); 0.9% physiological serum versus Curcuma longa (200 mg/kg/day); Curcuma longa (50 mg/kg/day) versus Curcuma longa 
(200 mg/kg/day).
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 Figures 4 to 6 compare the sulfomucin 
and sialomucin content found in the colon 
segments without fecal flow after intervention 
with saline or 50 mg/kg/day or 200 g/kg/day of 
curcumin oil extract over a four-week period.
 ■ Discussion
 Given that the main factor responsible 
for colitis appearing in the excluded colon is 
OFRs, many studies on antioxidant substances 
have been conducted. OFRs have been 
shown to be effective in animal models18. 
Studies on curcumin in the ulcerative colitis 
(UC) have been conducted and have shown 
benefits both in rats and in humans. Sugimoto 
et al.25 used curcumin mixed into the feed 
administered to rats in which colitis had been 
induced using trinitrobenzene sulfonic acid 
and observed that a histological improved 
occurred. In humans, Holt et al.21 administered 
curcumin to five patients with Crohn’s disease 
and UC, and observed that the clinical 
symptoms improved. Hanai et al.23 showed 
in a randomized study on individuals with UC 
that those who were administered curcumin 
and sulfasalazine together maintained a more 
sustained clinical response than did those 
who received salicylate alone. Kumar et al.22 
	  
Figure 4 - Colon segment without fecal flow after 
intervention with saline over a four-week period.
Figure 5 - Colon segment without fecal flow after 
intervention with 50 mg/kg/day of curcumin oil 
extract over a four-week period.
Figure 6 - Colon segment without fecal flow after 
intervention with 200 mg/kg/day of curcumin oil 
extract over a four-week period.
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conducted the first systematic review of the 
literature and showed that curcumin was 
effective for sustaining the clinical condition 
of patients with UC21-23. Given the effective 
response of UC to curcumin, it is valid to 
suppose that it would also be effective in 
cases of colitis due to an excluded colon, 
considering that the clinical, endoscopic and 
histopathological characteristics of these two 
conditions are similar5-26. 
 It is noteworthy that most studies that 
have used curcumin have not demonstrated any 
toxicity and have shown negligible side effects 
when used on humans27. The fact that curcumin 
is insoluble in water should also be borne in 
mind, given that this makes its absorption 
within the gastrointestinal tract more difficult 
and leads to the need to administer high doses 
of curcumin in order to reach serum levels. 
Nonetheless, this medication has been found 
to attain high concentrations in the intestinal 
lumen, which corroborates the notion that 
topical action is perhaps more important than 
systemic action27. 
 There are several ways of evaluating 
tissue injury. It has been shown that the issue 
acid and neutral mucin content in intestinal 
segments deprived of transit is reduced, which 
has led to a belief that oxidative stress interferes 
with production of these proteins1,5. Nonose 
et al.17 demonstrated that deviation of the 
fecal transit diminished the expression of acid 
mucins in the segments deprived of intestinal 
transit and that this alteration in expression 
was time-dependent. They also reported that 
the quantities of sulfomucins and sialomucins 
were generally constant on the surface of 
the normal colon. However, inversion of 
their proportions is often considered to be a 
pathological alteration. 
 Given the clinical and histopathological 
similarities between colitis of an excluded 
colon and UC, it is conceivable to believe that 
evolution of chronic inflammatory processes 
to dysplasia and neoplasia may occur in cases 
of colitis of an excluded colon, just as occurs 
in IBD. Likewise, it is feasible to believe that 
quantification of sulfomucin and sialomucin 
expression in the colon mucosa may be a possible 
means of assessing the therapeutic efficacy of 
different substances that are used, including 
curcumin. The antioxidant action of this 
substance is thought to prevent development 
of dysplasia and subsequently, colorectal 
cancer17. However, it should be emphasized 
that the inverse presentation of acid mucin 
expression in IBD and colitis of an excluded 
colon, along with the increasing incidence of 
colorectal cancer among individuals with UC, 
suggests that other intraluminal factors may be 
involved in this distinct pattern of sulfomucin 
and sialomucin expression. It is possible 
that different pattern of tissue acid mucin 
expression may be related to lower possibility 
of neoplastic transformation5.
 Given that curcumin has antioxidant 
effects and that it is a medication of low toxicity 
and negligible side effects, it would seem to 
be of interest to study its effects in relation to 
colitis of an excluded colon, with evaluation 
of its effects on the pattern of acid mucin 
expression in the excluded colon segment. 
 This study had the aims of quantifying 
the tissue sulfomucin and sialomucin content 
in the mucosa of colon segments that had 
been deprived of fecal transit and ascertaining 
whether the quantity of acid mucins 
underwent any change after an intervention 
using curcumin. It was found that application 
of enemas of curcumin at concentrations of 50 
mg/kg/day and 200 mg/kg/day considerably 
increased the total acid mucin content of the 
colon segment that had been deprived of fecal 
transit, compared with a group of animas that 
was treated with 0.9% physiological serum. 
It is possible that the improvement in the 
inflammatory score levels and the increase 
in the sulfomucines and sialomucins content 
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found in the animals submitted to intervention 
with oil extract of curcumin in higher 
concentration may be related to the lower 
oxidative tissue stress due to the lower degree 
of neutrophil infiltrate.This corroborates our 
previous studies in the same group of animals 
that showed that curcumin had protective 
antioxidant and anti-inflammatory effects 
reducing the neutrophil infiltrate evaluated by 
immunohistochemistry tissue expression of 
myeloperoxidase1,28. 
 Previous studies that quantified the 
tissue acid mucin expression in situations 
of exclusion colitis in rats found that there 
was a significant reduction in sulfomucin and 
sialomucin content. This gives further value to 
the findings of the present study. It is believed 
that reduction of acid mucin levels, particularly 
sialomucins, is related to absence of SCFA5,17.
 It was also observed that the tissue 
quantities of sialomucins and sulfomucins 
became greater with higher doses of curcumin 
administered, and with longer periods of 
treatment. Thus, the results from the present 
study seem to confirm information from 
previous studies that showed that curcumin 
had a protective effect on the colon epithelium 
and which indirectly demonstrated that OFRs 
may have a role in the physiopathology of 
colitis of an excluded colon.
 ■ Conclusions
 Topical application of curcumin 
enemas to colon segments that had been 
excluded from fecal transit increased the tissue 
quantities of sulfomucins and sialomucins, 
which demonstrated that this therapy had a 
protective effect. This study also showed that 
the action of curcumin was dose and time-
dependent.
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